* STRATA Skin Sciences Inc reported a quarterly adjusted loss of 53 cents​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of -30 cents. The mean expectation of two analysts for the quarter was for a loss of 44 cents per share.

* Revenue fell 0.6% to $8.80 million from a year ago; analysts expected $8.54 million.

* STRATA Skin Sciences Inc's reported EPS for the quarter was a loss of 53 cents​.

* The company reported a quarterly loss of $2.12 million.

* STRATA Skin Sciences Inc shares had risen by 11.6% this quarter and lost 44.2% so far this year.

FORECAST CHANGES

* The mean earnings estimate of analysts had risen by about 26.7% in the last three months.​

* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

* The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for STRATA Skin Sciences Inc is 16.00 This summary was machine generated from LSEG data November 14 at 04:15 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,

MISSED

Sep. 30 2024 -0.44 -0.53 Missed

Jun. 30 2024 -0.70 -0.03 Beat

Mar. 31 2024 -0.64 -1.00 Missed

Dec. 31 2023 -0.20 -1.10 Missed